TEMT offers 2X daily exposure to an exciting AI-driven, tech-health story
NEW YORK, May 13, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today announced the launch of a new single stock leveraged ETF, the Tradr 2X Long TEM Daily ETF (Cboe: TEMT). The fund aims to deliver twice (200%) the daily performance of the common stock of Tempus AI, Inc. (Nasdaq: TEM), a technology company advancing precision medicine through the practical application of artificial intelligence, including generative AI, in healthcare.
Traders who are bullish on Tempus can utilize Tradr ETFs' new fund to take advantage of swings in TEM's daily stock price without using a margin account or by trading options. TEMT marks the first-ever leveraged product tied to TEM stock.
This launch comes on the heels of the introduction in late April of two first-to-market single-stock leveraged ETFs covering AppLovin (Nasdaq: APP) and D-Wave Quantum (NYSE: QBTS). Both ETFs, APPX and QBTX, respectively, have already garnered significant investor attention with both assets and trading volumes steadily increasing since listing. In 2022, Tradr ETFs became the first issuer to launch leveraged ETFs on single stocks, starting with TSLQ for Tesla and NVDS for Nvidia.
"Since its IPO in June 2024, Tempus has gained significant momentum through its differentiated business model and compelling growth potential," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "The Tempus story offers a unique narrative driven by a leading-edge software platform that uses artificial intelligence to improve the quality of clinical outcomes and ultimately patient care. It's a thrilling innovation play that investors are only starting to discover, and we are excited to be the first and only ETF issuer to have a TEM single-stock strategy in the market."
TEMT can be traded through brokerage accounts and allows investors to avoid the hassle of using margin and the complexity of options trading. With this launch, Tradr's lineup grows to 10 leveraged ETFs. The firm continues its mission of providing sophisticated investors with innovative trading tools that enhance their ability to express market views with precision and efficiency.
For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit www.tradretfs.com.
About Tradr ETFs Tradr ETFs are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.
IMPORTANT RISK INFORMATION Tradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.
Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.
Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.
The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.
ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective.
ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.
Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting www.tradretfs.com. The Prospectus should be read carefully before investing.
Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000673
